Japan Approves New DLBCL Cancer Treatment After Trial

A groundbreaking clinical trial has just given Japanese patients with an aggressive form of lymphoma a powerful new treatment option.

The SUNMO trial results convinced Japan's health ministry to approve the therapy as a new standard of care.